Last reviewed · How we verify
Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver Injury
The purpose of this study is to explore the efficacy and the safety of polyene phosphatidylcholine Injection in patients with acute drug-induced liver injury after 2-4 weeks of treatment.
Details
| Lead sponsor | Sichuan Haisco Pharmaceutical Group Co., Ltd |
|---|---|
| Phase | PHASE4 |
| Status | COMPLETED |
| Enrolment | 73 |
| Start date | Sat Apr 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Acute Drug Induced Liver Injury
Interventions
- Polyene phosphatidylcholine injection 930 mg QD
- Magnesium Isoglycyrrhizinate injection 200 mg QD
Countries
China